QNEEDS®

Enhanced Delivery for Maximum Absorption

Q-Needs® is superior from other CoQ10 options on the market today. Q-Needs® is a patent-pending, completely soluble, liquid, crystal-free solution of ubiquinol clinically proven to provide superior bioavailability. Superior bioavailability means better absorption of the nutrient from the gut into the blood, aimed to:

- Boost Cognitive Awareness
- Promote Antioxidant Health
- Support Cellular Energy Production
- Support heart and cardiovascular health
- Reduce frequency and duration of migraine pain

Coenzyme Q10 (CoQ10) is a completely-natural nutrient that plays a critical role in the production of energy by the mitochondria within cells. While technically not a “vitamin” because humans can make CoQ10, the production of CoQ10 by the body is insufficient in health and in disease, and much of the CoQ10 in the body is supplied by the diet. Click here to learn more about CoQ10.

Q-Needs® (CoQH-CF® from NeuroNeeds®) provides the ubiquinol form of CoQ10 in a highly bioavailable, natural, and easy-to-swallow softgel. Ubiquinol is the activated form of CoQ10, and about 80% of the CoQ10 in human blood is ubiquinol. Most CoQ10 products on the market is ubiquinone, which is much less bioavailable than ubiquinol. If a CoQ10 product is not labeled as ubiquinol or ubiquinone, it is highly likely to be ubiquinone, as it is far less expensive. Additionally, Q-Needs® is sourced from Kaneka®, which is one of the few sources of the highest-quality CoQ10 in the world.

Q-Needs® is a superior product from many other CoQ10 options on the market today. Q-Needs® is a patent-pending, completely soluble, liquid, crystal-free solution of ubiquinol clinically proven to provide superior bioavailability. Better bioavailability means better absorption of the nutrient from the gut into the blood. Only about 1% of most commercially-available CoQ10 is absorbed. Oxidation of ubiquinol to ubiquinone prior to absorption is also a key problem with lesser brands. Bioavailability and stability of Kaneka® ubiquinol in Q-Needs® are enhanced by the addition of low dosing of natural ingredients, including alpha-lipoic acid, d-Limonene, and capric and caprylic acids. Click here to learn more about the enhanced bioavailability and stability of Q-Needs®, including the results of a study. Visit the tab above "LEARN MORE ABOUT QNEEDS" for more about the enhanced bioavailability and stability of Q-Needs®, including the results of a study.

Q-Needs® is vegan and free of all common allergens (including soy, peanuts, nuts, gluten, casein/milk, rice, corn, shellfish, fish, and egg), as well as artificial flavors and colors.

Additionally, Q-Needs® softgels are soft, small, and easy to swallow.   In neurodevelopmental disorders such as autism, ADHD, and epilepsy, CoQ10 must also pass the blood-brain barrier. Studies are very difficult to conduct on brain bioavailability due to invasiveness, however, many physicians recommend ubiquinol over ubiquinone in the treatment of brain disorders due in large part to assumed enhanced bioavailability (passage) into brain.

CoQ10 is often recommended in health and in disease. In health, studies show that as we get older, the body's ability to convert ubiquinone to ubiquinol diminishes, which may contribute to symptoms such as fatigue and reduced energy. In disease, CoQ10 is oftentimes recommended by physicians in the treatment of neurodevelopmental disorders, functional conditions (e.g. chronic pain, fatigue, nausea), and mitochondrial/metabolic disorders. Click here to learn more about the use of CoQ10 in autism and other disorders.

Take 1 softgel twice daily or as directed by a healthcare professional.
Caution: Consult a physician if pregnant/nursing, taking medication, or have a medical condition.

DOSING:

Dosing of SpectrumNeeds® and QNeeds®, as with any dietary supplement, is individualized, and best discussed with your physician. There are many factors involved in dosing, including age/size, condition and severity, blood levels of key nutrients, and individual tolerances. With those caveats, in order to provide a high-degree of antioxidant support, Dr. Boles often recommends the following starting dosing in his patients:

Children 20-40 kg (44-88 lbs):

• SpectrumNeeds® two scoops twice daily (4 scoops per day)
• QNeeds® 200 mg twice daily (4 gel capsules per day)

Adults 60 or more kg (over 133 lbs):

• SpectrumNeeds® three scoops twice daily (6 scoops per day)
• QNeeds® 300 mg twice daily (6 gel capsules per day)

Bioavailability and Stability

Extracted from the oil of citrus fruits, food-grade d-Limonene acts as a non-polar organic solvent that solubilizes CoQ10, without causing significant chemical interactions or degradation.  The end result is a liquid, crystal-free, completely soluble CoQ10 — providing superior bioavailability — that does not require heat or synthetic chemical solvents and that fully resists recrystallization at ambient temperatures.

Researchers compared the oral bioavailability of a single dose of 100 mg of Kaneka® ubiquinol, as a hermetically sealed softgel, versus a single dose of 100 mg of a standard CoQ10 supplement, consisting of crystalline powder in a two-piece hard shell. Ten subjects over 60 years of age participated in this randomized, double-blind, two-arm crossover human clinical trial published in the Journal of Functional Foods. Clinical trial published in the Journal of Functional Foods Compared to CoQ10 crystalline powder, supplementation with Kaneka® ubiquinol achieved:

• Significantly higher plasma concentrations of CoQ10 at 5, 6, 8, 12, 24, 48 and 72 hours post-dose.
• 4.3 times higher plasma area under the curve of reduced and total CoQ10.
• 3.3 times higher plasma area under the curve of oxidized CoQ10.
• Faster peak blood levels of CoQ10, with total CoQ10 reaching maximum plasma concentrations 15.5 ± 29.6 hours after supplementation, versus 26.5 ± 25.8 for CoQ10 crystalline powder.

The researchers concluded that “...reduced Coenzyme Q10 liquid softgel formulation was found to be superior to the commercial formulation of Coenzyme Q10 for bioavailability.”